Cargando…

Inhibitory Effects of Medroxyprogesterone Acetate on Mouse Endometrial Carcinogenesis

The present study was undertaken to examine the effects of cyclic administration of low‐dose progestogen on endometrial carcinogenesis in mice. A total of 115 female ICR mice, 10 weeks of age, were divided into four experimental and control groups. Mice in groups 1–3 received laparotomy and were inj...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niwa, Kenji, Morishita, Shigeo, Murase, Toshiko, Itoh, Naoki, Tanaka, Takuji, Mori, Hideki, Tamaya, Teruhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1995
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920903/ https://www.ncbi.nlm.nih.gov/pubmed/7559094 http://dx.doi.org/10.1111/j.1349-7006.1995.tb02460.x

Ejemplares similares

Enhancing Effects of Estrogens on Endometrial Carcinogenesis Initiated by N‐Methyl‐N‐nitrosourea in ICR Mice
por: Niwa, Kenji, et al.
Publicado: (1993)

Effects of Tamoxifen on Endometrial Carcinogenesis in Mice
por: Niwa, Kenji, et al.
Publicado: (1998)

Preventive Effects of Glycyrrhizae radix Extract on Estrogen‐related Endometrial Carcinogenesis in Mice
por: Niwa, Kenji, et al.
Publicado: (1999)

Semi‐quantitative Analysis of DNA Topoisomerase‐I mRNA Level Using Reverse Transcription‐Polymerase Chain Reaction in Cancer Cell Lines: Its Relation to Cytotoxicity against Camptothecin Derivative
por: Niwa, Kenji, et al.
Publicado: (1994)

Inhibitory Effects of Toremifene on N‐Methyl‐N‐nitrosourea and Estradiol‐17β‐induced Endometrial Carcinogenesis in Mice
por: Niwa, Kenji, et al.
Publicado: (2002)

Preventive Effects of Isoflavones, Genistein and Daidzein, on Estradiol‐17β‐related Endometrial Carcinogenesis in Mice
por: Lian, Zenglin, et al.
Publicado: (2001)

Inhibitory Effect of Ellagic Acid on N‐2‐Fluorenylacetamide‐induced Liver Carcinogenesis in Male ACI/N Rats
por: Tanaka, Takuji, et al.
Publicado: (1988)

Effect of medroxyprogesterone acetate on the response of the rat mammary gland to carcinogenesis.
por: Russo, I. H., et al.
Publicado: (1989)

Alteration of p53 gene in ovarian carcinoma: clinicopathological correlation and prognostic significance.
por: Niwa, K., et al.
Publicado: (1994)

Rapid Induction of Endometrial Carcinoma in ICR Mice Treated with N‐Methyl‐N‐nitrosourea and 17β‐Estradiol
por: Niwa, Kenji, et al.
Publicado: (1991)

Synergistic Effect of Radiation on Colon Carcinogenesis Induced by Methylazoxymethanol Acetate in ACI/N Rats
por: Tanaka, Takuji, et al.
Publicado: (1993)

Inhibitory Effects of the Natural Products Indole‐3‐carbinol and Sinigrin during Initiation and Promotion Phases of 4‐Nitroquinoline 1‐Oxide‐induced Rat Tongue Carcinogenesis
por: Tanaka, Takuji, et al.
Publicado: (1992)

Efficacy and prognosis of adjuvant treatment of endometrial cancer with medroxyprogesterone acetate COX regression analysis
por: Wang, Ding-Ran
Publicado: (2023)

Hypercalcemia after the Discontinuation of Medroxyprogesterone Acetate
por: Yuasa-Shibasaki, Erina, et al.
Publicado: (2017)

Medroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trial()()
por: Nanda, Kavita, et al.
Publicado: (2016)

Levonorgestrel-releasing intrauterine system (Mirena) in compare to medroxyprogesterone acetate as a therapy for endometrial hyperplasia
por: Behnamfar, Fariba, et al.
Publicado: (2014)

Medroxyprogesterone acetate inhibits wound closure of human endometrial epithelial cells and stromal fibroblasts in vitro
por: Patel, Mickey V., et al.
Publicado: (2021)

The effect of depot medroxyprogesterone acetate on tenofovir alafenamide in rhesus macaques
por: Daly, Michele B., et al.
Publicado: (2020)

Effects of X‐Irradiation on N‐Methyl‐N‐nitrosourea‐induced Multi‐organ Carcinogenesis in Rats
por: Morishita, Vukio, et al.
Publicado: (1993)

Measurement of endometrial thickness by transvaginal ultrasonography to predict pathological response to medroxyprogesterone acetate in patients with grade 1 endometrioid adenocarcinoma
por: SATO, MASAKAZU, et al.
Publicado: (2016)

Combination of imatinib mesylate with lithium chloride and medroxyprogesterone acetate is highly active in Ishikawa endometrial carcinoma in vitro
por: Bilir, Ayhan, et al.
Publicado: (2011)

Growth of poorly differentiated endometrial carcinoma is inhibited by combined action of medroxyprogesterone acetate and the Ras inhibitor Salirasib
por: Faigenbaum, Raya, et al.
Publicado: (2013)

Modifying Effects of Fungal and Herb Metabolites on Azoxymethane‐induced Intestinal Carcinogenesis in Rats
por: Yoshimi, Naoki, et al.
Publicado: (1992)

Medroxyprogesterone Acetate (Provera) in the Treatment of Metastatic Renal Cancer*
por: Bloom, H. J. G.
Publicado: (1971)

Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630
por: Potkul, Ronald K, et al.
Publicado: (2016)

Medroxyprogesterone acetate causes the alterations of endoplasmic reticulum related mRNAs and lncRNAs in endometrial cancer cells
por: Cao, Wenjiao, et al.
Publicado: (2019)

Inhibitory Effects of Dietary Protocatechuic Acid and Costunolide on 7,12‐Dimethylbenz[a]anthracene‐induced Hamster Cheek Pouch Carcinogenesis
por: Ohnishi, Masami, et al.
Publicado: (1997)

Chemopreventive Effect of a Xanthine Oxidase Inhibitor, 1′‐Acetoxychavicol Acetate, on Rat Oral Carcinogenesis
por: Ohnishi, Masami, et al.
Publicado: (1996)

Metformin attenuates the production and proliferative effects of prolactin induced by medroxyprogesterone acetate during fertility-sparing treatment for endometrial cancer
por: Gu, Wenjing, et al.
Publicado: (2022)

Incidence of Galactorrhea in Young Women Using Depot-Medroxyprogesterone Acetate
por: Omar, Hatim A., et al.
Publicado: (2006)

Ovulation suppression following subcutaneous administration of depot medroxyprogesterone acetate
por: Taylor, Douglas J., et al.
Publicado: (2022)

Depot Medroxyprogesterone Acetate Use and the Development and Progression of Uterine Leiomyoma
por: Harmon, Quaker E., et al.
Publicado: (2022)

Chemoprevention of Azoxymethane‐induced Rat Colon Carcinogenesis by a Xanthine Oxidase Inhibitor, 1′‐Acetoxychavicol Acetate
por: Tanaka, Takuji, et al.
Publicado: (1997)

Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?
por: Yamagami, Wataru, et al.
Publicado: (2018)

Depo-Provera (depot medroxyprogesterone acetate) use after bariatric surgery
por: Lam, Clarissa, et al.
Publicado: (2016)

Changes in Hematologic Parameters during Treatment with Medroxyprogesterone Acetate for Breast Cancer
por: Yamamoto, Hitoshi, et al.
Publicado: (1991)

Medroxyprogesterone acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and endometrial carcinoma: trial protocol for a prospective, randomised, open, blinded-endpoint design, dose-response trial (FELICIA trial)
por: Mitsuhashi, Akira, et al.
Publicado: (2020)

Phase II study of high-dose medroxyprogesterone acetate in advanced malignant melanoma.
por: Becher, R., et al.
Publicado: (1989)

Combined Bezafibrate and Medroxyprogesterone Acetate: Potential Novel Therapy for Acute Myeloid Leukaemia
por: Khanim, Farhat L., et al.
Publicado: (2009)

Comparison of Sexual Dysfunction in Women Using Depo-Medroxyprogesterone Acetate (DMPA) and Cyclofem
por: Ozgoli, Giti, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_o17c237lhftpeukr7cvd60tq1f